Tuesday 8 April 2014

Anticoagulation

Evidence Based Reports

Newer oral anticoagulants (2013) [WeMeRec] NEW

Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism (2013) [NICE] NEW

Warfarin initiation nomograms for venous thromboembolism (2013)[Cochrane] NEW

Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism (2013)[Cochrane] NEW

Antiplatelet and anticoagulation for patients with prosthetic heart valves(2013)[Cochrane] updated

Antiplatelet and Anticoagulant Treatments for Unstable Angina/Non–ST Elevation Myocardial Infarction (2013)[AHRQ][Executive Summary] NEW

Tinzaparin versus Dalteparin or Enoxaparin for the Treatment of Venous Thromboembolism in Adults: Safety and Guidelines (2013)[CADTH] NEW

Low Molecular Weight Heparins Versus Unfractionated Heparin for Thromboprophylaxis in Surgery, Cancer and General Medicine: A Review of the Cost-effectiveness and Safety (2013)[CADTHNEW

Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism (2012) [NICE] NEW

Apixaban for the prevention of venous thromboembolism after total hip or knee replacement in adults (2012)[NICE] NEW

Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment (2012)[Cochrane] NEW

Thrombophilia testing for prevention of recurrent venous thromboembolism(2012)[Cochrane] updated

Comparative effectiveness of warfarin and new oral anticoagulants for the management of atrial fibrillation and venous thromboembolism: a systematic review (2012)[DARE] NEW

Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy (2011)[Cochrane] NEW

Vitamin K antagonists versus antiplatelet therapy after transient ischaemic attack or minor ischaemic stroke of presumed arterial origin (2011) [Cochrane] updated

Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer (2011) [Cochrane]

Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer (2011)[Cochrane]

Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer (2011)[Cochrane]

Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation (2010)[Cochrane]

Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm (2010)[Cochrane] NEW

Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism (2010)[Cochrane]

Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement (2010)[Cochrane]

Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation (2010) [Cochrane] updated

Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism (2010)[DARE]

Dabigatran etexilate (Pradaxa) for secondary prevention of venous thromboembolism (VTE)(2010)[National Horizon Scanning Centre]

Anticoagulation for Venous Thromboembolism (2010)[theNNT]

Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation (2010) [Cochrane]

Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults(2009)[NICE]

Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism(2009)[Cochrane]

Interventions for preventing venous thromboembolism following abdominal aortic surgery(2009)[Cochrane]

Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome(2008)[Cochrane]

Anticoagulants for preventing recurrence following presumed non-cardioembolic ischaemic stroke or transient ischaemic attack (2008)[Cochrane]

Self-monitoring and self-management of oral anticoagulation (2008)[Cochrane]

Idrabiotaparinux for the treatment of DVT and/or PE and secondary prevention of venous thromboembolism (2008)[National Horizon Scanning Centre]

Dabigatran etexilate (Pradaxa) for acute symptomatic venous thromboembolism (2008)[National Horizon Scanning Centre]

AVE-5026 for the prevention of venous thromboembolism in patients at risk (2008)[National Horizon Scanning Centre]

Anticoagulants for acute ischaemic stroke (2008)[Cochrane]

Anticoagulants versus non-steroidal anti-inflammatories or placebo for treatment of venous thromboembolism (2008)[Cochrane]

Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke (2008)[Cochrane]

Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-leg immobilization (2008)[Cochrane]

Anticoagulants versus non-steroidal anti-inflammatories or placebo for treatment of venous thromboembolism (2008) [Cochrane]

Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks (2006) [Cochrane]

Monitoring anticoagulant therapy in primary care (2007) [WeMeRec]

Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks (2004) [Cochrane]





Clinical Guidelines

Anticoagulation (2014)[Map of Medicine] updated

Oral anticoagulation (2013)[CKS] updated
 
Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing (2012)[NICE] NEW
 
Effects on routine coagulation screens and assessment of anticoagulant intensity in patients taking oral dabigatran or rivaroxaban: Guidance from the British Committee for Standards in Haematology (2012) [BSCH] NEW
 
Guidelines on the diagnosis and management of heparin induced thrombocytopenia: second edition (2012) [BSCH] NEW
 
Guidelines on the investigation and management of venous thrombosis at unusual sites (2012)[BSCH] NEW
 
Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies (2012)[BSCH] NEW

Guideline on the investigation, management and prevention of venous thrombosis in children (2011)[BSCH]

Guidelines on oral anticoagulation with warfarin – fourth edition (2011)[BSCH]

Venous Thromboembolism and Hormone Replacement Therapy (2011) [RCOG]

Prevention and management of venous thromboembolism (2010)[SIGN]

Venous thromboembolism:reducing the risk (2010)[NICE]

Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures (2008)[British Soc Gastroenterology]



eTextbooks

Oral Anticoagulants (2013)[Mentor] updated

Starting patients on anticoagulants: how to do it (2007) [BMJ Learning]

Maintaining patients on anticoagulants: how to do it (2007) [BMJ Learning]



Recent articles in core journals

Dabigatran versus warfarin in patients with mechanical heart valves (2013)[NEJM] NEW

Sustained impact of anticoagulant control achieved in an anticoagulation management service after transfer of management to the primary care physician (2012) [Pharmacotherapy] NEW

Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. (2011)[Lancet]

Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study (2009)[BMJ]

Meta-analysis: travel and risk for venous thromboembolism (2009)[Annals of Internal Medicine]

Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W).(2008)[Stroke]

Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease: a meta-analysis of randomized trials(2008)[Arch Intern Med]

Oral anticoagulant and antiplatelet therapy and peripheral arterial disease (2007)[NEJM]


Clinical Queries

Is there any consensus as to whetherthe dose of warfarin should be adjusted prior to starting a course of antibiotics or is it suffice to check the INR after the course is completed? (2013)[ATTRACT] NEW

Is it safe for a woman with a history of venous thromboembolism (VTE), currently being treated with anticoagulants, to use two desogestrel pills a day to remain amenorrhoeic? (2013) [FSRH] NEW

Is there any consensus as to how antimalarials should be used when patients are on warfarin (2012) [ATTRACT] NEW

Can a woman who has a heart valve replacement who is going to need warfarin for life use the progestogen-only implant? (2011)[FSRH]

How safe is it to perform a 'steroid injection' into a shoulder joint in someone taking Warfarin (2011)[ATTRACT]



Patient Information

Anticoagulant Medicines (2013) [NHS Choices] updated

Important

1. If you are a Welsh Primary Care Professional with a clinical query send it to ATTRACT online or email us at questions@attract.wales.nhs.uk or call 01495 332343.
2. If you would like to comment on this CME topic, or suggest a new topic for ATTRACTcme, go to the comments hyperlink below.http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD001100.pub3/abstract

No comments: